Skip to main content
SpringerLink
Log in

Einbindung neuer In-vitro-Diagnostika in die GKV (Teil 2)

Lösungsansätze aus vergleichender Perspektive

  • AUFSÄTZE
  • Published:
Medizinrecht Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Fakultät 11 – Fakultät für angewandte Sozialwissenschaften, Hochschule München, Am Stadtpark 20, 81243, München, Deutschland

    Simone von Hardenberg

  2. Max-Planck-Institut für Sozialrecht und Sozialpolitik, Amalienstraße 33, 80799, München, Deutschland

    Irene Domenici

  3. Fakultät Sozialwesen – Studienrichtung Sozialmanagement, Duale Hochschule Baden-Württemberg Heidenheim, Wilhelmstraße 10, 89518, Heidenheim a.d. Brenz, Deutschland

    Roman Grinblat LL.M.

Authors
  1. Simone von Hardenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irene Domenici
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roman Grinblat LL.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

von Hardenberg, S., Domenici, I. & Grinblat, R. Einbindung neuer In-vitro-Diagnostika in die GKV (Teil 2). MedR 39, 964–970 (2021). https://doi.org/10.1007/s00350-021-6004-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00350-021-6004-x

Search

Navigation